SNAP-8
Also known as: Snap-8, Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-3, Ac-EEMQRRAD-NH2, extended Argireline, octapeptide anti-wrinkle peptide
Cosmetic ingredient; not an approved drug; no therapeutic claims established
2 notable studies · 4 references
TLDR
SNAP-8 (acetyl octapeptide-3) is a cosmetic eight-amino-acid peptide, an extended version of Argireline, designed to mimic part of the nerve protein SNAP-25 and gently reduce the muscle signaling behind expression wrinkles. The idea is plausible, but no PubMed-indexed controlled study has tested SNAP-8 on its own. The only indexed human studies used multi-ingredient microneedle patches, so its independent effect remains unproven.
At a Glance
Classification: Synthetic acetylated, amidated octapeptide; SNAP-25-mimetic cosmetic peptide; topical "neurotransmitter-modulating" anti-wrinkle ingredient
SNAP-8 is a cosmetic peptide ingredient sold for "expression lines," the wrinkles that form where facial muscles repeatedly fold the skin, such as crow's feet and forehead lines. It is the eight-amino-acid big sibling of the better-known Argireline (acetyl hexapeptide-3/-8). Argireline is Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 (EEMQRR). SNAP-8 adds two more residues, alanine and aspartic acid, to the end: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 (EEMQRRAD). The name comes from SNAP-25, a nerve-ending protein whose N-terminal stretch the peptide imitates. The marketing idea is a gentle, topical, "Botox-like" effect: Botox also targets SNAP-25 (it cuts it), while SNAP-8 is meant to get in its way temporarily. Here is the catch: the published, independent evidence for SNAP-8 by itself is very thin. We found no PubMed-indexed controlled trial testing SNAP-8 alone. The two indexed human studies tested multi-ingredient microneedle patches in which acetyl octapeptide-3 was one of several actives. Most efficacy claims come from the ingredient manufacturer's own technical data, which is not peer-reviewed.
What Is SNAP-8?
SNAP-8 is a synthetic peptide designed for cosmetics. It is not a drug and not an injectable. SNAP-25 N-terminal sequence (natural nerve protein) ↓ Argireline: 6-residue mimic (EEMQRR) ↓ SNAP-8: 8-residue extension (EEMQRRAD), marketed as a stronger version. Its INCI (cosmetic ingredient) name has been listed as acetyl octapeptide-3 and later as acetyl glutamyl heptapeptide-3. Both names refer to the same marketed ingredient.
What Are Researchers Studying?
Expression wrinkles (crow's feet, forehead lines)
This is SNAP-8's only real use. The indexed human evidence consists of combination products tested around the eyes.
Microneedle delivery
Because peptides penetrate skin poorly, recent studies loaded acetyl octapeptide-3 into dissolving hyaluronic-acid microneedle patches, tiny needles that dissolve in the upper skin. These studies tested delivery systems plus ingredient mixtures, so they mostly tell us about the products.
Comparison with the Argireline family
The rationale for SNAP-8 is that a longer SNAP-25 mimic might interfere more effectively. No independent head-to-head study of SNAP-8 versus Argireline was found in PubMed.
How Does It Work?
Proposed mechanism, extrapolated mainly from Argireline research: Muscle contraction needs acetylcholine released from nerve endings ↓ release requires the SNARE complex (SNAP-25, syntaxin, VAMP) to fuse vesicles with the membrane ↓ a SNAP-25-mimicking peptide competes with native SNAP-25 for a place in the complex ↓ SNARE complexes form less efficiently → less neurotransmitter release ↓ slightly reduced muscle contraction → softer expression lines (claimed). Several big uncertainties: • The SNARE-interference data for this peptide family come mainly from Argireline lab work, not SNAP-8. • It is unclear how much of a topically applied, charged peptide gets through the skin barrier to nerve endings in muscle. • Even Argireline, when studied, showed a much weaker effect than botulinum toxin.
What Does the Research Show?
Human research
VERY LOW (for SNAP-8 itself) Two small human studies of microneedle patches containing acetyl octapeptide-3 along with other actives reported improvement in eye-area wrinkles. Because of the mixtures, the effect cannot be credited to SNAP-8.
Animal research
NOT ESTABLISHED No indexed animal studies of SNAP-8 were identified.
In-vitro research
LOW No indexed peer-reviewed in vitro studies of SNAP-8 were identified. The mechanism relies on Argireline research and manufacturer data.
Notable Studies
Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study
humanJournal: Journal of Cosmetic Dermatology. A 12-week single-center study applied hyaluronic-acid microneedle patches containing arginine/lysine polypeptide, acetyl octapeptide-3, palmitoyl tripeptide-5, adenosine and seaweed extracts to the outer eye area and forearm of people with aged skin. The authors reported a 25.8% decrease in fine lines and wrinkles, a 15.4% improvement in hydration, and increases in dermal density and thickness. The patches were well tolerated.
Limitations: Multi-ingredient product, so the effect cannot be attributed to SNAP-8. Single-center design, and the abstract describes no placebo control. Industry-linked authors.
View publication →Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities
humanJournal: Annals of Dermatology. Twenty-four healthy adults applied a microneedle patch containing acetyl octapeptide-3, L-ascorbic acid 2-glucoside and sodium cyclic lysophosphatidic acid under one eye overnight, and a hyaluronic-acid-only placebo patch under the other, for 28 days. The active side showed better eye-wrinkle improvement, elasticity and lifting, plus lower water loss, with no adverse effects.
Limitations: Small, short, split-face study of a three-active combination product. The specific contribution of SNAP-8 cannot be separated.
View publication →What We Still Don't Know
• Whether SNAP-8 alone reduces wrinkles in a controlled human trial; none is indexed in PubMed • Whether it reaches nerve endings in facial muscle after topical application • Whether it truly interferes with SNARE complex formation in human tissue, as opposed to lab systems • Whether it outperforms Argireline, as marketed • Effective concentration and how much formulation and delivery matter • Long-term effects of repeated use • How results compare with botulinum toxin, which is a far stronger and well-studied treatment. The literature on SNAP-8 is very thin. Most claims rely on manufacturer data and on research into its shorter sibling, Argireline.
Related Compounds
Recent publications
Latest titles from PubMed, not reviewed by Aminodex. Not an endorsement. See all on PubMed ↗
Take the SNAP-8 research with you.
Get the Aminodex SNAP-8 Brief—a concise summary of the research, notable studies, evidence types, limitations, and references.
One-time email. We do not add you to any mailing list.
Sources & References
- Avcil M, Akman G, Klokkers J, Jeong D, Çelik A. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: a monocentric clinical study. J Cosmet Dermatol. 2020;19(2):328–337.
- Shin JY, Han D, Yoon KY, Jeong DH, Park YI. Clinical safety and efficacy evaluation of a dissolving microneedle patch having dual anti-wrinkle effects with safe and long-term activities. Ann Dermatol. 2024;36(4):215–224.
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. (Background: parent hexapeptide, not SNAP-8.)
- Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl hexapeptide-8 in cosmeceuticals: a review of skin permeability and efficacy. Int J Mol Sci. 2025. (Background on the Argireline family and skin penetration.)
Supplier Listings
Disclosure: The owner of Aminodex operates the supplier(s) marked below. These listings are promotion for businesses we own, not independent recommendations. Read our disclosures.